Schedule

9:45 – 10:30 Welcome and badges distribution

Morning session

10:30 – 10:45 Introductory words of academic and industry liasons

Prof Eric Allemann (UniGe)

10:45 – 11:05 Targeting conserved pathways of aging and disease with nutraceuticals

Dr Vincenzo Sorrentino – Team leader (NIHS)

11:05 – 11:25 Bringing cancer immunotherapy to patients with innovative translational models

Dr Nikolche Gjorevski – Scientist (Roche)

11:25 – 11:45 Controlled‐release systems for biologics

Dr Pierre Maudens – (Novartis)

11:45 – 12:05 TBD

TBD

12:05 – 13:30 Networking lunch break

Afternoon session

13:30 – 13:50 New strategies to improve mitochondrial function in health and disease: translation from bench to clinic

Dr Davide D’Amico – Amazentis

13:50 – 14:10 My journey in cell and gene therapy

Dr Floriane Groell – (Novartis)

14:10 – 14:30 Angiopoietin 4: Player or Bystander in Retinal Vascular Disease

Dr Dragana Avramovic – (Roche)

14:30 – 14:50 Pre-clinical efficacy of an oral ferroportin inhibitor for the treatment of beta-thalassemia

Dr Naja Nyffenegger – (Vifor)

14:50 – 15:25 Coffee break

15:25 – 15:45 TBD

Vincent Grek (Nestlé Health Sciences)

15:45 – 16:05 Career transition from academia to industry

Justine Badée (Novartis)

16:05 – 16:25 TBD

Dr Remi Villenave (Roche)

16:25 – 16:30 Closing remarks